Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leiden Thrombosis Recurrence Risk Prevention: Tailored Treatment After a First Venous Thromboembolism

NCT06087952 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT06087952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06087952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leiden Thrombosis Recurrence Risk Prevention: Tailored Treatment After a First Venous Thromboembolism
Lead sponsor
Leiden University Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 18, 2021
Completion date
June 1, 2027
Enrollment
608 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism, venous thromboembolism, venous thromboses